Showing results (31-40 of 302) with videos related to
Sort By:
Pageof 31
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndromeJoseph P McEvoy, Trina B AllenBiochemistry|December 5, 2008
Redox reactions of the non-heme iron in photosystem II: an EPR spectroscopic studyJames P McEvoy, Gary W BrudvigThe Journal of Clinical Psychiatry|May 14, 2021
How to Evaluate Patients and Educate Them About Self-Examinations for Tardive Dyskinesia Between AppointmentsJoseph P McEvoy, Andrew A NierenbergThe Journal of Clinical Psychiatry|January 30, 2020
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and SchizophreniaJoseph P McEvoy, Daniel E KremensThe Journal of Clinical Psychiatry|October 1, 1979
Case studies in neuropsychiaatry. II: Conversion pseudodementiaJ P Mcevoy, C E WellsThe Journal of Clinical Psychiatry|March 6, 2018
What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment OptionsJ Sloan Manning, Joseph P McEvoyClinical Therapeutics|January 1, 1987
Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophreniaJ P McEvoy, M McCue, S FreterThe Journal of Hospital Infection|September 29, 2009
Co-ordinated approach to healthcare worker influenza vaccination in an area health serviceT Ballestas, S P McEvoy, J Doyle, et al.British Journal of Haematology|January 1, 1983
Idiopathic autoantibody that inhibits fibrin monomer polymerizationS Ghosh, P McEvoy, B A McVerryJournal of Clinical Psychopharmacology|June 1, 1986
Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot studyJ P McEvoy, R L Stiller, R FarrPageof 31